GWSG
MRNA icon

GPS Wealth Strategies Group’s Moderna MRNA Stock Holding History

GPS Wealth Strategies Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.8K Sell
95
-98
-51% -$2.66K ﹤0.01% 517
2025
Q3 		$4.99K Sell
193
-58
-23% -$1.62K ﹤0.01% 1263
2025
Q2 		$6.92K Sell
251
-107
-30% -$2.82K ﹤0.01% 1123
2025
Q1 		$10.2K Buy
358
+50
+16% +$1.77K ﹤0.01% 996
2024
Q4 		$12.8K Sell
308
-170
-36% -$8.13K ﹤0.01% 895
2024
Q3 		$31.9K Hold
478
– – ﹤0.01% 690
2024
Q2 		$56.8K Buy
478
+43
+10% +$5.44K 0.01% 512
2024
Q1 		$46.4K Hold
435
– – 0.01% 529
2023
Q4 		$43.3K Sell
435
-78
-15% -$6.56K 0.01% 522
2023
Q3 		$53K Buy
513
+180
+54% +$20.1K 0.01% 473
2023
Q2 		$40.5K Sell
333
-123
-27% -$16.4K 0.01% 538
2023
Q1 		$70K Buy
+456
New +$75.2K 0.01% 416
2022
Q4 		– Sell
-412
Closed -$49K – 721
2022
Q3 		$49K Sell
412
-69
-14% -$10.5K 0.01% 435
2022
Q2 		$69K Sell
481
-561
-54% -$80.2K 0.02% 385
2022
Q1 		$179K Sell
1,042
-28
-3% -$4.71K 0.04% 220
2021
Q4 		$272K Sell
1,070
-145
-12% -$42.4K 0.06% 182
2021
Q3 		$468K Sell
1,215
-14
-1% -$5.16K 0.12% 110
2021
Q2 		$289K Hold
1,229
– – 0.07% 159
2021
Q1 		$160K Buy
+1,229
New +$178K 0.05% 221

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

GPS Wealth Strategies Group's MRNA Position: Q4 2025 in Review

GPS Wealth Strategies Group reduced its Moderna (MRNA) stake by 51% in Q4 2025, selling an estimated $2.66K and leaving 95 shares worth $2.8K. The position accounts for ﹤0.01% of the portfolio, ranked #517.

GPS Wealth Strategies Group first reported a position in MRNA in Q1 2021 and has held it in 19 quarters since. The position peaked at $468K in Q3 2021. 672 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • GPS Wealth Strategies Group held 95 shares of Moderna worth $2.8K as of Q4 2025.
  • GPS Wealth Strategies Group sold 98 Moderna shares in Q4 2025, an estimated $2.66K.
  • Moderna made up ﹤0.01% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #517 holding.
  • GPS Wealth Strategies Group first reported a position in Moderna in Q1 2021 and has held it in 19 quarters since.
  • GPS Wealth Strategies Group's Moderna position peaked at $468K in Q3 2021.
  • 672 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.